The 3rd Decentralized and Hybrid Trials World Congress 2027 – Europe will convene leading experts, regulators, technology innovators, and patient representatives to discuss strategies, share best practices, and showcase new technologies driving the next phase of decentralized research. Attendees can look forward to an engaging, collaborative, and forward thinking exchange of ideas designed to advance the global adoption and impact of DCTs.